MIST
Milestone Pharmaceuticals Inc
0.8657$
+5.6%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -100.0% | – | – | – | -84.6% | +134.9% | – | |
| – | +2,116.8% | +0.0% | -95.1% | -3.8% | +2,168.0% | -95.2% | +3.7% | -10.7% | +36.0% | +105.9% | -54.3% | – | |
| – | – | – | – | – | – | – | – | – | – | -89.1% | +213.7% | – | |
| – | -19.1% | -33.0% | -22.6% | +40.8% | -0.6% | +26.3% | -26.3% | +9.4% | +37.6% | -39.1% | +4.4% | – | |
| – | -20.3% | +17.3% | +27.6% | -25.8% | +6.9% | +29.1% | -27.2% | -13.9% | +57.0% | -5.1% | +369.5% | – | |
| – | -13.1% | -21.5% | -7.8% | -0.5% | +28.4% | +66.2% | -38.9% | -5.2% | +58.3% | +27.3% | +9.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.9% | +1.8% | +1.7% | +1.8% | +1.8% | +1.7% | +1.7% | +1.7% | +1.9% | +319.8% | +14.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -106.6% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.